Skip to main content
Erschienen in: Journal of NeuroVirology 1/2020

13.09.2019

Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS

verfasst von: Wei Tu, Patricia A. Chen, Noshin Koenig, Daniela Gomez, Esther Fujiwara, M. John Gill, Linglong Kong, Christopher Power

Erschienen in: Journal of NeuroVirology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Neurocognitive impairment (NCI) among HIV-infected patients is heterogeneous in its reported presentations and frequencies. To determine the prevalence of NCI and its associated subtypes as well as predictive variables, we investigated patients with HIV/AIDS receiving universal health care. Recruited adult HIV-infected subjects underwent a neuropsychological (NP) test battery with established normative (sex-, age-, and education-matched) values together with assessment of their demographic and clinical variables. Three patient groups were identified including neurocognitively normal (NN, n = 246), HIV-associated neurocognitive disorders (HAND, n = 78), and neurocognitively impaired-other disorders (NCI-OD, n = 46). Univariate, multiple logistic regression and machine learning analyses were applied. Univariate analyses showed variables differed significantly between groups including birth continent, quality of life, substance use, and PHQ-9. Multiple logistic regression models revealed groups again differed significantly for substance use, PHQ-9 score, VACS index, and head injury. Random forest (RF) models disclosed that classification algorithms distinguished HAND from NN and NCI-OD from NN with area under the curve (AUC) values of 0.87 and 0.77, respectively. Relative importance plots derived from the RF model exhibited distinct variable rankings that were predictive of NCI status for both NN versus HAND and NN versus NCI-OD comparisons. Thus, NCI was frequently detected (33.5%) although HAND prevalence (21%) was lower than in several earlier reports underscoring the potential contribution of other factors to NCI. Machine learning models uncovered variables related to individual NCI types that were not identified by univariate or multiple logistic regression analyses, highlighting the value of other approaches to understanding NCI in HIV/AIDS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69(18):1789–1799CrossRef Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69(18):1789–1799CrossRef
Zurück zum Zitat Belete T, Medfu G, Yemiyamrew E (2017) Prevalence of HIV associated neurocognitive deficit among HIV positive people in ethiopia: a cross sectional study at Ayder Referral Hospital. Ethiop J Health Sci 27(1):67–76CrossRef Belete T, Medfu G, Yemiyamrew E (2017) Prevalence of HIV associated neurocognitive deficit among HIV positive people in ethiopia: a cross sectional study at Ayder Referral Hospital. Ethiop J Health Sci 27(1):67–76CrossRef
Zurück zum Zitat Boucekine M, Loundou A, Baumstarck K, Minaya-Flores P, Pelletier J, Ghattas B, Auquier P (2013) Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study. BMC Med Res Methodol 13:20CrossRef Boucekine M, Loundou A, Baumstarck K, Minaya-Flores P, Pelletier J, Ghattas B, Auquier P (2013) Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study. BMC Med Res Methodol 13:20CrossRef
Zurück zum Zitat Brandt J, Benedict R (2001) Hopkins verbal learning test-revised (HVLT-R). Psychological Assessment Resources, Lutz Brandt J, Benedict R (2001) Hopkins verbal learning test-revised (HVLT-R). Psychological Assessment Resources, Lutz
Zurück zum Zitat Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J et al (2016) Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neuro-Oncol 22(3):349–357 Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J et al (2016) Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neuro-Oncol 22(3):349–357
Zurück zum Zitat Crane HM, Van Rompaey SE, Dillingham PW, Herman E, Diehr P, Kitahata MM (2006) A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care. AIDS Patient Care STDs 20(3):161–174CrossRef Crane HM, Van Rompaey SE, Dillingham PW, Herman E, Diehr P, Kitahata MM (2006) A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care. AIDS Patient Care STDs 20(3):161–174CrossRef
Zurück zum Zitat Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 42(9):1736–1739CrossRef Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 42(9):1736–1739CrossRef
Zurück zum Zitat Delis DC, Kaplan E, Kramer JH, D-KEFSSA (2001) TX: the psychological corporation. Delis-Kaplan executive function system. The Psychological Corporation, San Antonio Delis DC, Kaplan E, Kramer JH, D-KEFSSA (2001) TX: the psychological corporation. Delis-Kaplan executive function system. The Psychological Corporation, San Antonio
Zurück zum Zitat Gisslen M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 11:356CrossRef Gisslen M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 11:356CrossRef
Zurück zum Zitat Gomez D, Power C, Gill MJ, Fujiwara E (2017) Determinants of risk-taking in HIV-associated neurocognitive disorders. Neuropsychology. 31(7):798–810CrossRef Gomez D, Power C, Gill MJ, Fujiwara E (2017) Determinants of risk-taking in HIV-associated neurocognitive disorders. Neuropsychology. 31(7):798–810CrossRef
Zurück zum Zitat Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D (2013) Alzheimer’s disease neuroimaging I. Random forest-based similarity measures for multi-modal classification of Alzheimer’s disease. Neuroimage 65:167–175CrossRef Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D (2013) Alzheimer’s disease neuroimaging I. Random forest-based similarity measures for multi-modal classification of Alzheimer’s disease. Neuroimage 65:167–175CrossRef
Zurück zum Zitat Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 75(23):2087–2096CrossRef Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 75(23):2087–2096CrossRef
Zurück zum Zitat Kamminga J, Bloch M, Vincent T, Carberry A, Brew BJ, Cysique LA (2017) Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 39(8):753–767CrossRef Kamminga J, Bloch M, Vincent T, Carberry A, Brew BJ, Cysique LA (2017) Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 39(8):753–767CrossRef
Zurück zum Zitat Kim D, Jewison DL, Milner GR, Rourke SB, Gill MJ, Power C et al (2001) Can J Neurol Sci 28:228–231CrossRef Kim D, Jewison DL, Milner GR, Rourke SB, Gill MJ, Power C et al (2001) Can J Neurol Sci 28:228–231CrossRef
Zurück zum Zitat Kongs SK, Thompson LL, Iverson GL, Heaton RK (2000) Wisconsin card sorting test-64 card version (WCST-64) Lutz, FL:PAR Kongs SK, Thompson LL, Iverson GL, Heaton RK (2000) Wisconsin card sorting test-64 card version (WCST-64) Lutz, FL:PAR
Zurück zum Zitat Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613CrossRef Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613CrossRef
Zurück zum Zitat McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66(6):407–437CrossRef McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66(6):407–437CrossRef
Zurück zum Zitat McCombe JA, Vivithanaporn P, Gill MJ, Power C (2013) Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Med 14(2):99–107CrossRef McCombe JA, Vivithanaporn P, Gill MJ, Power C (2013) Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Med 14(2):99–107CrossRef
Zurück zum Zitat Mothobi NZ, Brew BJ (2012) Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 25(1):4–9CrossRef Mothobi NZ, Brew BJ (2012) Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 25(1):4–9CrossRef
Zurück zum Zitat Nakagawa F, May M, Phillips A (2013) Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 26(1):17–25CrossRef Nakagawa F, May M, Phillips A (2013) Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 26(1):17–25CrossRef
Zurück zum Zitat Patel A, Parikh R, Howell EH, Hsich E, Landers SH, Gorodeski EZ (2015) Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. Circ Heart Fail 8(1):8–16CrossRef Patel A, Parikh R, Howell EH, Hsich E, Landers SH, Gorodeski EZ (2015) Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. Circ Heart Fail 8(1):8–16CrossRef
Zurück zum Zitat Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A, Gill MJ, Power C (2006) Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 59(5):816–824CrossRef Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A, Gill MJ, Power C (2006) Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 59(5):816–824CrossRef
Zurück zum Zitat Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C (2010) Ocular complications of ARG. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. Clin Infect Dis 51(8):947–956CrossRef Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C (2010) Ocular complications of ARG. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. Clin Infect Dis 51(8):947–956CrossRef
Zurück zum Zitat Robertson K, Liner J, Heaton R (2009) Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev 19(2):232–249CrossRef Robertson K, Liner J, Heaton R (2009) Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev 19(2):232–249CrossRef
Zurück zum Zitat Roehr B (2015) UNAIDS celebrates success in halting spread of HIV and sets goals for 2030. BMJ. 351:h3832CrossRef Roehr B (2015) UNAIDS celebrates success in halting spread of HIV and sets goals for 2030. BMJ. 351:h3832CrossRef
Zurück zum Zitat Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG, For the Women’s Interagency HIV Study (2017) Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology. 89(15):1594–1603CrossRef Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG, For the Women’s Interagency HIV Study (2017) Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology. 89(15):1594–1603CrossRef
Zurück zum Zitat Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 86(4):334–340CrossRef Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 86(4):334–340CrossRef
Zurück zum Zitat Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248CrossRef Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248CrossRef
Zurück zum Zitat Schretlen DJ, Testa SM, Pearlson GD (2010) GD. Clock-drawing test scoring approach from the Calibrated Neuropsychological Normative System. Lutz, FL: Psychological Assessment Resources Schretlen DJ, Testa SM, Pearlson GD (2010) GD. Clock-drawing test scoring approach from the Calibrated Neuropsychological Normative System. Lutz, FL: Psychological Assessment Resources
Zurück zum Zitat Smail RC, Brew BJ (2018) HIV-associated neurocognitive disorder. Handb Clin Neurol 152:75–97CrossRef Smail RC, Brew BJ (2018) HIV-associated neurocognitive disorder. Handb Clin Neurol 152:75–97CrossRef
Zurück zum Zitat Smith A (1973) Symbol digit modalities test. Western Psychological Services, Los Angeles Smith A (1973) Symbol digit modalities test. Western Psychological Services, Los Angeles
Zurück zum Zitat Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14(4):403–418CrossRef Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14(4):403–418CrossRef
Zurück zum Zitat Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA, AGEhIV Cohort Study Group (2015) Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS. 29(5):547–557PubMed Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA, AGEhIV Cohort Study Group (2015) Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS. 29(5):547–557PubMed
Zurück zum Zitat Tierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP (2017) A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neuro-Oncol 23(3):404–421 Tierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP (2017) A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neuro-Oncol 23(3):404–421
Zurück zum Zitat Trites RL (1977) Neuropsychological test manual. Royal Ottawa Hospital, Ottawa Trites RL (1977) Neuropsychological test manual. Royal Ottawa Hospital, Ottawa
Zurück zum Zitat Tymchuk S, Gomez D, Koenig N, Gill MJ, Fujiwara E, Power C (2017) Associations between depressive symptomatology and neurocognitive impairment in HIV/AIDS. Can J Psychiatr 706743717737029 Tymchuk S, Gomez D, Koenig N, Gill MJ, Fujiwara E, Power C (2017) Associations between depressive symptomatology and neurocognitive impairment in HIV/AIDS. Can J Psychiatr 706743717737029
Zurück zum Zitat van den Dries LWJ, Wagener MN, Jiskoot LC, Visser M, Robertson KR, Adriani KS, van Gorp ECM (2017) Neurocognitive impairment in a chronically well-suppressed HIV-infected population: the Dutch TREVI Cohort Study. AIDS Patient Care STDs 31(8):329–334CrossRef van den Dries LWJ, Wagener MN, Jiskoot LC, Visser M, Robertson KR, Adriani KS, van Gorp ECM (2017) Neurocognitive impairment in a chronically well-suppressed HIV-infected population: the Dutch TREVI Cohort Study. AIDS Patient Care STDs 31(8):329–334CrossRef
Zurück zum Zitat Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 75(13):1150–1158CrossRef Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 75(13):1150–1158CrossRef
Metadaten
Titel
Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS
verfasst von
Wei Tu
Patricia A. Chen
Noshin Koenig
Daniela Gomez
Esther Fujiwara
M. John Gill
Linglong Kong
Christopher Power
Publikationsdatum
13.09.2019
Verlag
Springer International Publishing
Erschienen in
Journal of NeuroVirology / Ausgabe 1/2020
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-019-00791-6

Weitere Artikel der Ausgabe 1/2020

Journal of NeuroVirology 1/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.